APA (7th ed.) Citation

S, B., EA, M., KE, J., E, S., K, M., H, Y., . . . N, A. (2020). Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration, 21(1-2), 15. https://doi.org/10.1080/21678421.2019.1672750

Chicago Style (17th ed.) Citation

S, Babu, et al. "Selection Design Phase II Trial of High Dosages of Tamoxifen and Creatine in Amyotrophic Lateral Sclerosis." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 21, no. 1-2 (2020): 15. https://doi.org/10.1080/21678421.2019.1672750.

MLA (9th ed.) Citation

S, Babu, et al. "Selection Design Phase II Trial of High Dosages of Tamoxifen and Creatine in Amyotrophic Lateral Sclerosis." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 21, no. 1-2, 2020, p. 15, https://doi.org/10.1080/21678421.2019.1672750.